Italia markets closed

Dow Jones
39.826,52
+19,75(+0,05%)
Nasdaq
16.794,59
-0,29(-0,00%)
Nikkei 225
38.946,93
-122,75(-0,31%)
EUR/USD
1,0858
-0,0004(-0,03%)
Bitcoin EUR
64.272,25
+1.783,44(+2,85%)
CMC Crypto 200
1.522,99
+34,45(+2,31%)

NVCR May 2024 15.000 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

7,00

-0,20

(-2,78%)

In data: 03:56PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in